Available doses: 10mg/5mg, 10mg/10mg, 10mg/20mg, 10mg/40mg
Patients pay a single generic co-pay for the generic
Co-pay between $5 to $25 p.m. based on patient's insurance
No Prior Auth required (please ignore if PA shows in EMR/EHR)
Use GoodRx: Patients typically pay $15 to $30 p.m.
On rosuvastatin-ezetimibe 40-10 mg, most CHD patients achieved their LDL-C goal† of < 70 mg/dL
Only 35% of CHD patients on the highest dose of rosuvastatin achieved LDL-C goal† of < 70 mg/dL
† In the Explorer Study, 469 patients aged ≥ 18 years with hypercholesterolemia and a history of CV risk were randomized on rosuvastatin + ezetimibe 40 mg/10 mg vs. rosuvastatin 40 mg for a total of 6-weeks. Primary endpoint was % of patients at LDL-C goal < 100 mg/dL. Secondary endpoint for CHD patients was % at LDL-C goal < 70 mg/dL.
ezetimibe-rosuvastatin is a generic version of Roszet (rosuvastatin-ezetimibe) tablets
Roszet adverse experiences1 are expected to be similar to those with co-administered rosuvastatin
and ezetimibe taken separately.
|Rosuvastatin (AEs ≥2% of patients)|
|Adverse Reaction||Placebo N=382||Total Rosuvastatin 5 mg-40 mg N=744|
|Ezetimibe with S tatins (AEs ≥2% of patients)|
|Adverse Reaction||All Statins (%), n=9361||Ezetimibe + statins (%) N=11,308|
|Upper respiratory tract infection||2.8%||2.9%|
|Pain in extremity||1.9%||2.1%|
GoodRx is a trademark of GoodRx, Inc.
Important Safety Information